vs
Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and DORIAN LPG LTD. (LPG). Click either name above to swap in a different company.
PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($276.3M vs $120.0M, roughly 2.3× DORIAN LPG LTD.). DORIAN LPG LTD. runs the higher net margin — 39.3% vs 26.4%, a 12.9% gap on every dollar of revenue. Over the past eight quarters, PATHWARD FINANCIAL, INC.'s revenue compounded faster (21.0% CAGR vs -7.9%).
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
Dorian LPG Ltd. is a leading international shipping company focused on the seaborne transportation of liquefied petroleum gas (LPG). It owns and operates a modern fleet of very large gas carriers, serving energy and petrochemical industry clients across key markets including North America, Asia and Europe.
CASH vs LPG — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $276.3M | $120.0M |
| Net Profit | $72.9M | $47.2M |
| Gross Margin | — | — |
| Operating Margin | — | 42.8% |
| Net Margin | 26.4% | 39.3% |
| Revenue YoY | — | 48.7% |
| Net Profit YoY | — | 120.9% |
| EPS (diluted) | $3.35 | $1.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $276.3M | — | ||
| Q4 25 | $173.1M | $120.0M | ||
| Q3 25 | $186.7M | $124.1M | ||
| Q2 25 | $195.8M | $84.2M | ||
| Q1 25 | $274.8M | $75.9M | ||
| Q4 24 | $182.6M | $80.7M | ||
| Q3 24 | $179.5M | $82.4M | ||
| Q2 24 | $188.6M | $114.4M |
| Q1 26 | $72.9M | — | ||
| Q4 25 | $35.2M | $47.2M | ||
| Q3 25 | $38.8M | $55.4M | ||
| Q2 25 | $42.1M | $10.1M | ||
| Q1 25 | $75.0M | $8.1M | ||
| Q4 24 | $30.0M | $21.4M | ||
| Q3 24 | $33.5M | $9.4M | ||
| Q2 24 | $44.9M | $51.3M |
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | 42.8% | ||
| Q3 25 | 25.9% | 47.8% | ||
| Q2 25 | 24.1% | 18.5% | ||
| Q1 25 | 33.2% | 19.4% | ||
| Q4 24 | 19.8% | 29.0% | ||
| Q3 24 | 20.9% | 23.2% | ||
| Q2 24 | 27.1% | 48.5% |
| Q1 26 | 26.4% | — | ||
| Q4 25 | 20.3% | 39.3% | ||
| Q3 25 | 20.8% | 44.6% | ||
| Q2 25 | 21.5% | 12.0% | ||
| Q1 25 | 27.3% | 10.7% | ||
| Q4 24 | 16.4% | 26.5% | ||
| Q3 24 | 18.7% | 11.4% | ||
| Q2 24 | 23.8% | 44.9% |
| Q1 26 | $3.35 | — | ||
| Q4 25 | $1.57 | $1.11 | ||
| Q3 25 | $1.69 | $1.30 | ||
| Q2 25 | $1.81 | $0.24 | ||
| Q1 25 | $3.14 | $0.17 | ||
| Q4 24 | $1.23 | $0.50 | ||
| Q3 24 | $1.34 | $0.22 | ||
| Q2 24 | $1.78 | $1.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $157.6M | $294.5M |
| Total DebtLower is stronger | $59.5M | $513.2M |
| Stockholders' EquityBook value | $850.7M | $1.1B |
| Total Assets | $7.1B | $1.8B |
| Debt / EquityLower = less leverage | 0.07× | 0.47× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $157.6M | — | ||
| Q4 25 | $331.2M | $294.5M | ||
| Q3 25 | $120.6M | $268.3M | ||
| Q2 25 | $258.3M | $277.9M | ||
| Q1 25 | $254.2M | $316.9M | ||
| Q4 24 | $597.4M | $314.5M | ||
| Q3 24 | $158.3M | $348.6M | ||
| Q2 24 | $298.9M | $353.3M |
| Q1 26 | $59.5M | — | ||
| Q4 25 | $33.5M | $513.2M | ||
| Q3 25 | $33.5M | $526.4M | ||
| Q2 25 | $33.4M | $539.6M | ||
| Q1 25 | $33.4M | $553.3M | ||
| Q4 24 | $33.4M | $565.9M | ||
| Q3 24 | $33.4M | $579.0M | ||
| Q2 24 | $33.3M | $592.1M |
| Q1 26 | $850.7M | — | ||
| Q4 25 | $854.5M | $1.1B | ||
| Q3 25 | $858.0M | $1.1B | ||
| Q2 25 | $819.0M | $1.0B | ||
| Q1 25 | $814.7M | $1.0B | ||
| Q4 24 | $758.3M | $1.1B | ||
| Q3 24 | $822.5M | $1.1B | ||
| Q2 24 | $748.4M | $1.1B |
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.6B | $1.8B | ||
| Q3 25 | $7.2B | $1.8B | ||
| Q2 25 | $7.2B | $1.7B | ||
| Q1 25 | $7.0B | $1.8B | ||
| Q4 24 | $7.6B | $1.8B | ||
| Q3 24 | $7.5B | $1.9B | ||
| Q2 24 | $7.5B | $1.9B |
| Q1 26 | 0.07× | — | ||
| Q4 25 | 0.04× | 0.47× | ||
| Q3 25 | 0.04× | 0.49× | ||
| Q2 25 | 0.04× | 0.52× | ||
| Q1 25 | 0.04× | 0.53× | ||
| Q4 24 | 0.04× | 0.53× | ||
| Q3 24 | 0.04× | 0.53× | ||
| Q2 24 | 0.04× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $80.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.71× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $108.3M | $80.8M | ||
| Q3 25 | $303.7M | $46.4M | ||
| Q2 25 | $30.4M | $814.5K | ||
| Q1 25 | $188.3M | $50.2M | ||
| Q4 24 | $-71.7M | $24.3M | ||
| Q3 24 | $143.1M | $57.3M | ||
| Q2 24 | $113.2M | $41.2M |
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | — | ||
| Q3 25 | $300.3M | — | ||
| Q2 25 | $27.7M | — | ||
| Q1 25 | $184.7M | — | ||
| Q4 24 | $-73.8M | — | ||
| Q3 24 | $138.8M | — | ||
| Q2 24 | $111.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | — | ||
| Q3 25 | 160.9% | — | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | 67.2% | — | ||
| Q4 24 | -40.4% | — | ||
| Q3 24 | 77.3% | — | ||
| Q2 24 | 58.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 1.71× | ||
| Q3 25 | 7.83× | 0.84× | ||
| Q2 25 | 0.72× | 0.08× | ||
| Q1 25 | 2.51× | 6.20× | ||
| Q4 24 | -2.39× | 1.14× | ||
| Q3 24 | 4.27× | 6.08× | ||
| Q2 24 | 2.52× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
LPG
Segment breakdown not available.
